市場調查報告書
商品編碼
1454747
糖尿病照護設備市場 - 按產品(血糖監測設備、胰島素輸送設備)、最終用途(醫院、診斷中心) - 全球預測,2024 年 - 2032 年Diabetes Care Devices Market - By Product (Blood Glucose Monitoring Devices, Insulin Delivery Devices ), End-Use (Hospitals, Diagnostic Centers) - Global Forecast, 2024 - 2032 |
由於久坐的生活方式和不健康的飲食習慣,全球糖尿病盛行率不斷上升,預計從 2024 年到 2032 年,糖尿病照護設備市場規模將以 10% 的CAGR擴大。根據 CDC 的數據,美國共有 3,840 萬人患有糖尿病。不斷進步的技術發展正在促進更高效和方便用戶使用的設備的開發,以提高患者的依從性和採用率。
人們越來越認知到糖尿病患者定期監測和管理血糖水平的重要性,這將增加對這些設備的需求。許多地區實施糖尿病護理優惠報銷政策以及容易患糖尿病相關併發症的老年人口不斷增加也將補充行業的發展。
糖尿病護理設備市場按產品、最終用途和地區分類。
就產品而言,到2032年,胰島素輸送設備領域的市場價值將以10.2%的成長率成長。技術創新正在導致更方便用戶使用和方便的胰島素輸送設備的開發。全球糖尿病盛行率不斷上升,加上胰島素治療的日益普及,正在加速胰島素輸送設備的吸引力。提高患者對胰島素治療依從性的措施的躍進也將擴大產品的採用。
預計在 2024 年至 2032 年間,家庭護理最終用途領域的糖尿病護理設備行業佔有率將實現 10.4% 的CAGR。這可歸因於人們越來越偏愛家庭糖尿病管理,因為這些設備為患者提供了便利性和舒適性。家庭護理患者。不斷成長的技術進步鼓勵開發適合家庭環境的緊湊且易於使用的設備,進一步促進產品在家庭護理環境中的採用。
從地區來看,由於人們對糖尿病管理的認知不斷提高、糖尿病患病率不斷上升以及政府支持舉措的推出,預計到 2032 年,歐洲糖尿病護理設備行業規模將以 9.7% 的成長率擴大。創新血糖監測系統和胰島素輸送設備的開發正在提高該地區患者糖尿病管理解決方案的有效性和便利性。
Diabetes Care Devices Market size is projected to expand at 10% CAGR from 2024 to 2032, led by the rising prevalence of diabetes globally, owing to sedentary lifestyles and unhealthy dietary habits. According to the CDC, total 38.4 million people in the U.S. have diabetes. Rising technological developments are promoting the development of more efficient and user-friendly devices for improving patient compliance and adoption.
The growing awareness about the importance of regular monitoring and management of blood glucose levels among diabetic patients will escalate the demand for the devices. The implementation of favorable reimbursement policies for diabetes care in many regions and the growing geriatric population prone to diabetes-related complications will also complement the industry progression.
The diabetes care devices market is segregated into product, end-use, and region.
In terms of product, the market value from the insulin delivery devices segment will rise at 10.2% growth rate until 2032. Innovations in technology are resulting in the development of more user-friendly and convenient insulin delivery devices. The increasing prevalence of diabetes globally, coupled with the rising adoption of insulin therapy are accelerating the appeal of insulin delivery devices. The jump in initiatives to enhance patient adherence to insulin therapy will also amplify the product adoption.
Diabetes care devices industry share from the homecare end-use segment is estimated to witness 10.4% CAGR between 2024 and 2032. This can be credited to the increasing preference for home-based management of diabetes due to the convenience and comfort provided by these devices to homecare patients. Growing technology improvements are encouraging development of compact and easy-to-use devices suitable for home settings, further boosting the product adoption in homecare settings.
Regionally, the Europe diabetes care devices industry size is anticipated to expand at 9.7% growth rate until 2032, on account of the increasing awareness about diabetes management, rising prevalence of diabetes, and the rollout of supportive government initiatives. The development of innovative glucose monitoring systems and insulin delivery devices are enhancing the effectiveness and convenience of diabetes management solutions for patients across the region.